🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an observer-blinded Phase 3 study to evaluate the safety and immuno...
Status
Completed
Location
Cleveland Clinic Abu Dhabi
Start Date
2022-03-18
Trial ID
NCT05249816
Treatments Being Tested
This is a randomized, phase II trial which will be conducted among voluntee...
Status
Unknown
Location
National Institute of Health
Start Date
2022-03-01
Trial ID
NCT05162482
Treatments Being Tested
Phase II, non-randomized, open-label, comparative, single center national t...
Status
Unknown
Location
Centre de recherche de Landreah
Start Date
2022-04-25
Trial ID
NCT05409300
Treatments Being Tested
Primary#Objectives #Immunogenicity:To demonstrate the non-inferiority of bi...
Status
Unknown
Location
Savannakhét Provincial hospital
Start Date
2022-10-19
Trial ID
NCT05686161
Treatments Being Tested
Randomized, open, multicenter, collaborative and adaptive non-inferiority t...
Status
Unknown
Location
Córdoba
Start Date
2021-08-03
Trial ID
NCT04988048
Treatments Being Tested
Coronavirus disease 2019 (COVID-19) is potentially a deadly disease caused ...
Status
Completed
Location
Royal College of Surgeons in Ireland - Bahrain
Start Date
2021-07-18
Trial ID
NCT04993560
Treatments Being Tested
This is a multicenter, international, randomized, active-controlled platfor...
Status
Unknown
Location
PanAmerican Clinical Research
Start Date
2022-03-16
Trial ID
NCT05293665
Treatments Being Tested
To expand the access and delivery of COVID-19 Vaccines in Africa (ECOVA), t...
Status
Unknown
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT04984408
This is an observer-blind, randomized study which aims to assess the immune...
Status
Unknown
Location
Madagascar Institute for Vaccine Research (MIVR), University of Antananarivo
Start Date
2021-12-29
Trial ID
NCT04998240